Clearing resistant gut bacteria: three FMT methods
Treatments studied
This trial tests three different ways to clear antibiotic-resistant bacteria from your gut using fecal microbiota transplant (FMT). It may help if you have a confirmed resistant infection and are looking for a treatment to reduce the risk of future infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have tested positive for antibiotic-resistant bacteria (like CRE, ESBL, VRE, or MRSA) in your gut at least 28 days ago, confirmed by two different tests
- Your neutrophil count (a type of infection-fighting white blood cell) is above 500 per microliter
- Your life expectancy is at least 12 months
- You can swallow large capsules or are able to undergo a colonoscopy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study tests whether a fecal microbiota transplant (FMT) can eliminate hard-to-treat bacteria in the gut, such as ESBL or carbapenem-resistant bacteria. If it works, it may reduce future infections and antibiotic-resistant illness.
This study tests a stool-based treatment (fecal microbiota treatment) to help remove “carbapenem-resistant” bacteria living in the gut. If you carry these bacteria without being sick, the goal is to reduce or stop that colonization.
This trial looks at a treatment made from stool donors (called fecal microbiome therapy) to help remove carbapenem-resistant gut bacteria in the body. It’s mainly for adults who recently tested positive for these bacteria on a rectal swab, and it checks whether the therapy can help eradicate the germs.
This study tests whether a fecal transplant (FMT) can remove certain antibiotic-resistant bacteria from your gut. It might help people who carry superbugs like CPE or VRE but aren't currently on antibiotics.
This trial tests whether taking capsules containing processed healthy donor stool (fecal microbiota transplant) can safely remove certain drug-resistant bacteria (like CRE, ESBL-E, and VRE) from your intestines. It may be an option for people who have these bacteria in their stool but are not currently being treated with antibiotics.
This trial tests whether a fecal transplant can remove multidrug-resistant bacteria from the gut, potentially reducing the risk of infections. It may help patients who carry these bacteria without symptoms.
Hear when a new Drug Resistance, Bacterial trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.